iSign Solutions (ISGN) 10-Q 14 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 14, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Communication Intelligence Corp	'
Entity Central Index Key	'0000727634	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Current Fiscal Year End Date	'--12-31	'
Entity Well-known Seasoned Issuer	'Yes	'
EntityVoluntaryFilers	'No	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	232,559,488

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'	'
Cash and cash equivalents	$415	$945	$486
Accounts receivable, net of allowance of $32 at June 30, 2014 and $22 at December 31, 2013	228	410	'
Prepaid expenses and other current assets	28	57	'
Total current assets	671	1,412	'
Property and equipment, net	15	17	'
Patents, net	1,110	1,290	'
Other assets	29	29	'
Total assets	1,825	2,748	'
Current liabilities:	'	'	'
Accounts payable	165	327	'
Accrued compensation	300	315	'
Other accrued liabilities	259	232	'
Deferred revenue	470	490	'
Total current liabilities	1,194	1,364	'
Deferred revenue long-term	15	74	'
Deferred rent	61	86	'
Derivative liability	22	25	'
Total liabilities	1,292	1,549	'
Commitments and Contingencies	'	'	'
Stockholders' deficit	'	'	'
Common Stock, $0.01 par value; 1,500,000 shares authorized; 232,560 issued and outstanding at June 30, 2014 December 31, 2013	2,390	2,390	'
Treasury shares, 6,500 shares at June 30, 2014 and December 31, 2013 respectively	-325	-325	'
Additional paid in capital	96,072	96,172	'
Accumulated deficit	-121,410	-119,184	'
Accumulated other comprehensive loss	-14	-14	'
Total CIC stockholder's equity (deficit)	1,069	1,735	'
Non-Controlling interest	-536	-536	'
Total stockholders' equity (deficit)	533	1,199	-357
Total liabilities and shareholders' equity	1,825	2,748	'
Series A-1 Preferred Stock [Member]	'	'	'
Stockholders' deficit	'	'	'
Preferred stock by class of stock	1,052	1,031	880
Total stockholders' equity (deficit)	1,052	1,031	880
Series B Preferred Stock [Member]	'	'	'
Stockholders' deficit	'	'	'
Preferred stock by class of stock	9,506	9,232	7,380
Total stockholders' equity (deficit)	9,506	9,232	7,380
Series C Preferred Stock [Member]	'	'	'
Stockholders' deficit	'	'	'
Preferred stock by class of stock	5,197	5,086	3,569
Total stockholders' equity (deficit)	5,197	5,085	3,569
Series D-1 Preferred Stock [Member]	'	'	'
Stockholders' deficit	'	'	'
Preferred stock by class of stock	3,693	3,345	'
Total stockholders' equity (deficit)	3,693	3,345	'
Series D-2 Preferred Stock [Member]	'	'	'
Stockholders' deficit	'	'	'
Preferred stock by class of stock	4,252	4,002	'
Total stockholders' equity (deficit)	$4,252	$4,002	'

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current assets:	'	'
Accounts receivable, allowance	$32,000	$22,000
Stockholders' deficit	'	'
Common Stock, par value	$0.01	$0.01
Common Stock, shares authorized	1,500,000,000	1,500,000,000
Common Stock, shares issued	232,560,000	232,560,000
Common Stock, shares outstanding	232,560,000	232,560,000
Treasury shares	6,500,000	6,500,000
Series A-1 Preferred Stock [Member]	'	'
Stockholders' deficit	'	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	1,073,000	1,031,000
Preferred stock, shares outstanding	1,073,000	1,031,000
Preferred stock, liquidation preference	1,073,000	'
Series B Preferred Stock [Member]	'	'
Stockholders' deficit	'	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	14,000,000	14,000,000
Preferred stock, shares issued	11,660,000	11,102,000
Preferred stock, shares outstanding	11,660,000	11,102,000
Preferred stock, liquidation preference	17,490,000	'
Series C Preferred Stock [Member]	'	'
Stockholders' deficit	'	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	9,000,000	9,000,000
Preferred stock, shares issued	4,734,000	4,508,000
Preferred stock, shares outstanding	4,734,000	4,508,000
Preferred stock, liquidation preference	7,101,000	'
Series D-1 Preferred Stock [Member]	'	'
Stockholders' deficit	'	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	6,000,000	6,000,000
Preferred stock, shares issued	4,409,000	3,415,000
Preferred stock, shares outstanding	4,409,000	3,415,000
Preferred stock, liquidation preference	4,409,000	'
Series D-2 Preferred Stock [Member]	'	'
Stockholders' deficit	'	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	9,000,000	9,000,000
Preferred stock, shares issued	5,436,000	4,783,000
Preferred stock, shares outstanding	5,436,000	4,783,000
Preferred stock, liquidation preference	$5,436,000	'

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue:	'	'	'	'
Product	$278	$93	$406	$164
Maintenance	195	170	368	334
Total revenues	473	263	774	498
Cost of sales:	'	'	'	'
Product	39	5	43	9
Maintenance	38	76	92	150
Research and development	532	580	1,072	1,092
Sales and marketing expense	331	284	639	594
General and administrative expense	454	496	914	1,092
Total operating costs and expenses	1,394	1,441	2,760	2,937
Loss from operations	-921	-1,178	-1,986	-2,439
Other income (expense), net	'	-1	2	-1
Interest Expense [Abstract]	'	'	'	'
Related Party	'	3	'	3
Other	245	'	245	'
Gain (loss) on derivative liability	-1	1	3	65
Net loss	-1,167	-1,181	-2,226	-2,378
Accretion of beneficial conversion feature, preferred shares:	'	'	'	'
Related party	-13	-107	-86	-140
Other	-12	-159	-313	-181
Preferred stock dividends:	'	'	'	'
Related party	-340	-272	-669	-534
Other	-319	-238	-612	-453
Income tax	'	'	'	'
Net loss before non-controlling interest	-1,851	-1,957	-3,906	-3,686
Net loss attributable to non-controlling interest	'	'	'	'
Net loss attributable to common stockholders	($1,851)	($1,957)	($3,906)	($3,686)
Basic and diluted loss per common share	($0.01)	($0.01)	($0.02)	($0.02)
Weighted average common shares outstanding, basic and diluted	232,560	225,824	232,560	225,803

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($2,226)	($2,378)
Adjustments to reconcile net loss to net cash used for operating activities:	'	'
Depreciation and amortization	185	191
Stock-based employee compensation	177	429
Warrants cost issued as interest expense	245	'
Gain on derivative liability	-3	-65
Changes in operating assets and liabilities:	'	'
Accounts receivable, net	182	540
Prepaid expenses and other assets	29	51
Accounts payable	-162	128
Accrued Compensation	-15	-36
Other accrued liabilities	3	16
Deferred revenue	-79	-130
Net cash used in operating activities	-1,664	-1,254
Cash flows from investing activities:	'	'
Acquisition of property and equipment	-4	-5
Net cash used in investing activities	-4	-5
Cash flows from financing activities:	'	'
Proceeds from issuance of short-term debt	'	250
Proceeds from exercise of warrants for cash	'	29
Proceeds from issuance of Series D preferred Stock, net of issuance costs of $51	1,138	1,150
Payments on short-term debt	'	250
Net cash provided by financing activities	1,138	1,179
Effect of exchange rate changes on cash and cash equivalents	'	'
Net decrease in cash and cash equivalents	-530	-80
Cash and cash equivalents at beginning of period	945	486
Cash and cash equivalents at end of period	415	406
Supplemental disclosure of cash flow information:	'	'
Interest paid	'	2
Income tax paid	'	'
Non-cash financing and investing transactions:	'	'
YTD Dividend Shares in Kind	1,281	987
Accretion of beneficial conversion feature on issuance of Preferred Stock dividends	$399	$321

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Parenthetical) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014
Net Cash Provided by (Used in) Financing Activities [Abstract]	'
Stock issuance costs	$51

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Comprehensive Loss (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Comprehensive income:	'	'	'	'
Net loss	($1,167)	($1,181)	($2,226)	($2,378)
Foreign currency translation adjustment	'	'	'	14
Total comprehensive loss	($1,167)	($1,181)	($2,226)	($2,364)

Nature_of_business_basis_of_pr

Nature of business, basis of presentation and summary of significant accounting policies	6 Months Ended
	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Nature of business, basis of presentation and summary of significant accounting policies	'
	1. Nature of business and summary of significant accounting policies
	Basis of Presentation
	The financial information contained herein should be read in conjunction with the Company's consolidated audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2013.
	The accompanying unaudited condensed consolidated financial statements of Communication Intelligence Corporation and its subsidiary (the "Company" or "CIC") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("GAAP") for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company's results of operations and cash flows for the periods presented. The Company's interim results are not necessarily indicative of the results to be expected for the entire year.
	The Company is a leading supplier of electronic signature products and the recognized leader in biometric signature verification. CIC enables companies to achieve truly paperless workflow in their electronic business processes by providing multiple signature technologies across virtually all applications. CIC's solutions are available both in software-as-a-service ("SaaS") and on-premise delivery models and afford "straight-through-processing," which can increase customer revenue by enhancing user experience and can also reduce costs through paperless and virtually error-free electronic transactions that can be completed significantly quicker than paper-based procedures. To date, the Company primarily has delivered biometric and electronic signature solutions to channel partners and end-user customers in the financial services industry.
	The Company's research and development activities have given rise to numerous technologies and products. The Company's core technologies can be referred to as "transaction-enabling" technologies. These technologies include various forms of electronic signatures, such as handwritten biometric, click-to-sign and others, as well signature verification, cryptography and the logging of audit trails to show signers' intent. These technologies can enable secure, legal and regulatory compliant electronic transactions that can enhance customer experience at a fraction of the time and cost required by traditional, paper-based processes. The Company's products include SignatureOne® Ceremony® Server, the iSign® suite of products and services, including iSign® Enterprise and iSign® Console™, Sign-it® and the iSign® toolkits.
	Going Concern
	The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at June 30, 2014, the Company's accumulated deficit was $121,410. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of June 30, 2014, the Company's cash balance was $415. These factors raise substantial doubt about the Company's ability to continue as a going concern.
	There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
	Reclassifications
	Certain prior year amounts have been reclassified between Series C Preferred Stock, Series D-1 Preferred Stock, Series D-2 Preferred Stock and Additional paid in capital on the accompanying condensed consolidated balance sheet to properly reflect accretion of the beneficial conversion feature on certain issuances of the Company's Preferred Stock. These reclassifications do not impact the condensed consolidated statement of operations or the condensed consolidated statement of cash flows.
	Accounting Changes and Recent Accounting Pronouncements
	Accounting Standards Issued But Not Yet Adopted
	Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies are not expected to have a material impact on the Company's financial position, results of operations and cash flows.

Concentrations

Concentrations	6 Months Ended
	Jun. 30, 2014
Risks and Uncertainties [Abstract]	'
Concentration Risk Disclosure [Text Block]	'
	2. Concentrations
	The following table summarizes accounts receivable and revenue concentrations:
		Accounts Receivable		Total Revenue		Total Revenue
		As of June 30,		for the three months		for the six months
				ended June 30,		ended June 30,
		2014	2013	2014	2013	2014	2013
	Customer #1	-	13%	-	-	-	-
	Customer #2	-	-	-	14%	-	14%
	Customer #3	25%	54%	-	-	-	-
	Customer #4	-	-	-	-	11%	-
	Customer #5	44%	-	32%	-	19%	-
	Customer #6	-	14%	-	-	-	-
	Customer #7	-	-	-	13%	-	14%
	Total concentration	69%	81%	32%	27%	30%	28%

Patents

Patents	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Patents	'
	3. Patents
	The Company performs intangible asset impairment analysis at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets.
	Management completed an analysis of the Company's patents as of December 31, 2013. Based on that analysis, the Company concluded that no impairment of the carrying value of the patents existed. The Company believes that no events or circumstances changed during the three and six months ended June 30, 2014 that would impact this conclusion.
	Amortization of patent costs was $89 and $180 for the three and six-month periods ended June 30, 2014 and $91 and $183 for the three and six month periods ended June 30, 2013, respectively.
	Intangible Assets
	The following table summarizes intangible assets:
	Amortizable intangible assets:	30-Jun-14		31-Dec-13
		Carrying	Accumulated	Carrying	Accumulative
		Amount	Amortization	Amount	Amortization
	Patents	$	$	$	$
		6,746	-5,636	6,745	-5,455

Derivative_Liability

Derivative Liability	6 Months Ended
	Jun. 30, 2014
Derivative liability [Abstract]	'
Derivative liability	'
	4. Derivative liability
	The Company has determined that a contract that would otherwise meet the definition of a derivative but is both (a) indexed to the Company's own stock and (b) classified in stockholders' equity in the statement of financial position would not be considered a derivative financial instrument. The Company applies a two-step model in determining whether a financial instrument or an embedded feature is indexed to an issuer's own stock and thus able to qualify for the scope exception.
	The Company issued certain warrants in connection with financing transactions from 2010 through 2012 that require liability classification because of certain provisions that may have resulted in an adjustment to the number of shares issued upon settlement and an adjustment to their exercise price. The Company classifies these warrants on its balance sheet as a derivative liability which is fair valued at each reporting period subsequent to the initial issuance. The Company used a simulated probability valuation model to value these warrants. Determining the appropriate fair-value model and calculating the fair value of warrants requires considerable judgment. Any change in the estimates (specifically, probabilities) used may cause the value to be higher or lower than that reported. The assumptions used in the model required significant judgment by management and include the following: volatility, expected term, risk-free interest rate, dividends, and warrant holders' expected rate of return, reset provisions based on expected future financings, projected stock prices, and probability of exercise. The estimated volatility of the Company's common stock at the date of issuance, and at each subsequent reporting period, is based on historical volatility. The risk-free interest rate is based on rates published by the government for bonds with a maturity similar to the expected remaining life of the warrants at the valuation date. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Dividends are estimated at 0% based on the Company's history of no common stock dividends.
	The fair value of the outstanding derivative liabilities at June 30, 2014, and December 31, 2013, was $22 and $25, respectively.
	Fair value measurements:
	Assets and liabilities measured at fair value as of June 30, 2014 and December 31, 2013:
		Value at	Quoted	Significant	Significant
			prices in	other	unobservable
			active	observable	inputs
			markets	inputs
			(Level 1)	(Level 2)	(Level 3)
		30-Jun-14
	Derivative liability	$	$	$	$
		22	-	-	22
		31-Dec-13
	Derivative liability	$	$	$	$
		25	-	-	25
	The fair value framework requires a categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:
	Level 1: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The Company's assets and liabilities measured at fair value, whether recurring or non-recurring, at June 30, 2014, and December 31, 2013, and the fair value calculation input hierarchy level that we have determined applies to each asset and liability category.
	Changes in the fair market value of the Level 3 derivative liability for the six-month period ended June 30, 2014 are as follows:
		Derivative Liability
	Balance at January 1, 2014	$
		25
	Gain on derivative liability	3
	Balance at June 30, 2014	$
		23

Net_loss_per_share

Net loss per share	6 Months Ended
	Jun. 30, 2014
Net loss per share [Abstract]	'
Net loss per share	'
	5. Net loss per share
	The Company calculates basic net loss per share, based on the weighted average number of shares outstanding, and when applicable, diluted income per share, which is based on the weighted average number of shares and potential dilutive shares outstanding.
	The following table lists shares and warrants that were excluded from the calculation of dilutive earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive:
		For the Six Months Ended
		30-Jun-14	30-Jun-13
	Stock options	71,987	70,472
	Warrants	105,230	135,359
	Preferred shares as if converted
	Series A-1Preferred Stock	7,664	7,079
	Series B Preferred Stock	269,105	243,796
	Series C Preferred Stock	210,412	194,888
	Series D-1 Preferred Stock	195,956	62,818
	Series D-2 Preferred Stock	108,713	87,997
	The following table is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the basic and diluted EPS calculations and sets forth potential shares of common stock that are not included in the diluted net loss per share calculation as the effect is antidilutive:
		Three Months Ended		Six Months Ended
		June 30,	June 30,	June 30,	June 30,
		2014	2013	2014	2013
	Numerator-basic and diluted net loss	$	$	$	$
		-1,851	-1,957	-3,906	-3,686
	Denominator-basic or diluted	232,560	225,824	232,560	225,803
	weighted average number of common
	shares outstanding
	Net loss per share - basic and diluted	$	$	$	$
		-0.01	-0.01	-0.02	-0.02

Line_of_credit

Line of credit	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	6. Line of Credit
	On May 6, 2014, the Company entered into a $2 million Credit Agreement with Venture Champion Asia Limited, an affiliate of ICG Global Limited (the "Lender"). Under the terms of the Credit Agreement, for a period of 18 months, the Company is permitted to borrow up to $2 million in unsecured indebtedness from the Lender. Each draw is subject to a 15% original issue discount, so that borrowing the full $2 million would result in an aggregate of $2.352 million in debt with fifty percent (50%) warrant coverage and also may be converted at the Lender's option into shares of the Company's Common Stock at an initial conversion price of $0.0275 per share.
	In connection with the Company's entry into the Credit Agreement, the Company issued to the Lender 10,909 warrants to purchase 10,909 shares of Common Stock. The warrants have a three year life and an exercise price of $0.0275 per share. The Company ascribed a value of $245 using the Black Scholes Pricing Model. The warrants valuation was charged to interest expense at June 30, 2014 (See Note 7).

Equity

Equity	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity [Abstract]	'
Stockholders' Equity	'
	7. Equity
	Share-based compensation expense is based on the estimated grant date fair value of the portion of share-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black Scholes valuation model.
	Forfeitures of share-based payment awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The estimated average forfeiture rate for the three months ended June 30, 2014 and 2013, was approximately 9.85% and 9.73%, respectively, based on historical data.
	Valuation and Expense Information:
	The weighted-average fair value of stock-based compensation is based on the single option valuation approach. Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options. The fair value calculations are based on the following assumptions:
		Six Months Ended	Six Months Ended
		30-Jun-14	30-Jun-13
	Risk free interest rate	0.04% - 4.89%	0.39% - 5.11%
	Expected life (years)	3.26 - 7.00	2.82 - 7.00
	Expected volatility	91.99% - 198.38%	91.99% - 198.38%
	Expected dividends	None	None
	The Company granted 2,500 stock options during the three and six months ended June 30, 2014. There were no stock options exercised during the three and six months ended June 30, 2014.
	The Company granted 26,554 stock options during the three and six months ended June 30, 2013. There were no stock options exercised during the three and six months ended June 30, 2013.
	The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and six months ended June 30, 2014 and 2013.
		Three Months Ended June 30,		Six Months Ended June 30,
		2014	2013	2014	2013
	Research and development	$	$	$	$
		21	49	48	245
	Sales and marketing	24	17	37	117
	General and administrative	37	100	83	42
	Director options	4	10	9	25
	Stock-based compensation	$	$	$	$
	expense	86	176	177	429
	A summary of option activity under the Company's plans as of June 30, 2014 and 2013 is as follows:
	Options	2014				2013
		Shares	Weighted	Weighted	Aggregate	Shares	Weighted	Weighted	Aggregate
			Average	Average	Intrinsic		Average	Average	Intrinsic
			Exercise	Remaining	Value		Exercise	Remaining	Value
			Price	Contractual			Price	Contractual
				Term				Term
	Outstanding	69,537	$		$	44,529	$		$
	at January 1,		0.05		-		0.05		2,230
	Granted	2,500	$		$	26,554	$		$
			0.03		7		0.04		1,188
	Exercised	-	$		$	-	$		$
			-		-		-		-
	Forfeited or	-50	$		$	-610	$		$
	expired		0.22		-		0.14		-85
	Outstanding	71,987	$	4.6	$	70,473	$	5.51	$
	at June 30		0.05		7		0.05		3,333
	Vested and	46,864	$	4.24	$	63,615	$	5.51	$
	expected to		0.05		-		0.05		3,009
	vest at June
	30
	Exercisable at	51,984	$	4.24	$	33,083	$	4.94	$
	30-Jun		0.05		-		0.05		1,638
	The following table identifies the range of outstanding and exercisable options as of June 30, 2014:
	Range of Exercise Prices	Options Outstanding			Options Exercisable
		Number	Weighted	Weighted	Number	Weighted
		Outstanding	Average	Average	Outstanding	Average
			Remaining	Exercise		Exercise
			Contractual	Price		Price
			Life (in years)
	$ 0.02 - $0.50	71,987	4.6	$	51,984	$
				0.05		0.05
	A summary of the status of the Company's non-vested shares as of June 30, 2014, is as follows:
	Nonvested Shares	Shares	Weighted Average
			Grant-Date
			Fair Value
	Non-vested at January 1, 2014	26,158	$
			0.04
	Granted	2,500	$
			0.03
Forfeited	-	$
		-
Vested	-8,655	$
		0.04
Non-vested at June 30, 2014	20,032	$
		0.04
As of June 30, 2014, there was a total of $317 unrecognized compensation expense related to non-vested share-based compensation arrangements granted under the plans. The unrecognized compensation expense is expected to be realized over a weighted average period of 2.8 years.
Preferred Shares
Information with respect to the class of Preferred Stock at June 30, 2014 is as follows:
Class of	Annual	Annual	Liquidation	Conversion	YTD	Total	Common
Preferred	Dividend	Dividend	Preference	Price	Dividend	Preferred	Shares to be
Stock		Payable, in			Shares in	Shares	issued if
		Cash or In			Kind	Outstanding	Fully
		Kind					Converted
Series A-1	8%	Quarterly in	$	$	41	1,073	7,664
		Arrears	1	0.14
Series B	10%	Quarterly in	$	$	558	11,660	269,105
		Arrears	1.5	0.0433
Series C	10%	Quarterly in	$	$	226	4,734	210,412
		Arrears	1.5	0.0225
Series D-1	10%	Quarterly in	$	$	201	4,409	195,956
		Arrears	1	0.0225
Series D-2	10%	Quarterly in	$	$	255	5,436	108,713
		Arrears	1	0.05
Information with respect to dividends issued on the Company's Preferred stock for the three and six month periods ended June 30, 2014 and June 30, 2013 is as follows:
	Dividends				Beneficial Conversion Feature Related to dividends
	Three Months Ended June 30,		Six Months Ended June 30,		Three Months Ended June 30,		Six Months Ended June 30,
	2014	2013	2014	2013	2014	2013	2014	2013
Series A-1	$	$	$	$	$	$	$	$
	21	19	41	37	-	-	-	-
Series B	$	$	$	$	$	$	$	$
	284	257	558	504	-	-	-	-
Series C	$	$	$	$	$	$	$	$
	115	107	226	210	13	83	50	126
Series D-1	$	$	$	$	$	$	$	$
	107	31	201	59	12	183	297	195
Series D-2	$	$	$	$	$	$	$	$
	132	96	255	177	-	-	52	-
Total	$	$	$	$	$	$	$	$
	659	510	1,281	987	25	266	399	321
Series A-1 Preferred Stock
The shares of Series A-1 Preferred Stock are convertible any time and are subordinate to the Series B, Series C and Series D Preferred Stock.
Series B Preferred Stock
The shares of Series B Preferred Stock are convertible at any time and are subordinate to the Series C and Series D Preferred Stock.
Series C Preferred Stock
The shares of Series C Preferred Stock are convertible into Common Stock at any time and are subordinate to the Series D Preferred Stock.
Series D Preferred Stock
The material terms of the Series D-1 and Series D-2 Preferred Stock, other than the initial conversion price, are essentially the same. The shares of Series D Preferred Stock are convertible at any time and rank senior to the Company's outstanding shares of Series A-1, Series B and Series C Preferred Stock, and of Common Stock with respect to dividend rights and liquidation preferences.
In May 2013, the Company completed a private placement of 230 units of Series D Preferred Stock consisting of one (1) share of Series D-1 Preferred Stock and four (4) shares of Series D-2 Preferred Stock. The private placement provided $1,150 in proceeds to the Company.
On December 31, 2013, the Company converted approximately $1,179 of short-term debt plus accrued interest into 786 shares of Series D-1 Preferred Stock and 393 shares of Series D-2 Preferred Stock. The investors can receive up to one hundred percent (100%) warrant coverage. These warrants are immediately exercisable and expire three (3) years from the date of issuance. See the warrant table below for more detail. The warrants are exercisable in whole or in part and contain a cashless exercise provision.
On December 31, 2013, the Company sold for $870 in cash, net of $40 administrative fee paid to SG Phoenix, 607 Shares of Series D-1 preferred Stock and 303 shares of Series D-2 Preferred Stock. The investors can receive up to one hundred percent (100%) warrant coverage. These warrants are immediately exercisable and expire three (3) years from the date of issuance. See the warrant table below for more detail. The warrants are exercisable in whole or in part and contain a cashless exercise provision.
In connection with the December 31, 2013, offering, the Company adjusted the number of shares of Series D-1 Preferred Stock and Series D-2 Preferred Stock issued to investors in the May 2013 offering described above, in order to give such investors shares of Series D-1 Preferred Stock and Series D-2 Preferred Stock in the same ratio as offered to Investors in the December 31, 2013, offering. This resulted in an exchange of 537 shares of Series D-2 Preferred into Series D-1 Preferred. The Company also issued warrants to purchase Common Stock in the same manner as offered to investors in the December 31, 2013, offering.
On February 7, 2014, the Company sold for $733 in cash, net of $47 administrative fee paid in cash to SG Phoenix and a nonrelated third party, 520 Shares of Series D-1 preferred Stock and 260 shares of Series D-2 Preferred Stock. The investors can receive up to one hundred percent (100%) warrant coverage. These warrants are immediately exercisable and expire December 31, 2016. See the warrant table below for more detail. The warrants are exercisable in whole or in part and contain a cashless exercise provision.
On March 6, 2014, the Company sold for $406 in cash, net of $4 in administrative fees paid in cash to an unrelated third party, 273 Shares of Series D-1 preferred Stock and 137 shares of Series D-2 Preferred Stock. The investors can receive up to one hundred percent (100%) warrant coverage. These warrants are immediately exercisable and expire December 31, 2016. See the warrant table below for more detail. The warrants are exercisable in whole or in part and contain a cashless exercise provision.
SG Phoenix received warrants to purchase 3,000 shares of Common stock, and two unrelated parties received warrants to purchase an aggregate of 1,600 shares of Common Stock in payment of administrative and finder's fees associated with the financings, in addition to the cash payments discussed above. These warrants are immediately exercisable and expire three (3) years from the date of issuance. The warrants are exercisable in whole or in part and contain a cashless exercise provision.
Preferred Stock Voting and Other Rights
Generally, the Company's Preferred Stock votes together on an as converted basis with the holders of Common Stock. In addition, the Company's Preferred Stock enjoys certain protective provisions, a liquidation preference and anti-dilution protection that are similar to one another.
Warrants
A summary of the warrant activity is as follows:
	30-Jun-14		30-Jun-13
	Warrants	Weighted	Warrants	Weighted
		Average		Average
		Exercise Price		Exercise Price
Outstanding at beginning of period	77,155	$	151,722	$
		0.0289		0.0269
Issued	72,589	$	-	$
		0.0275		-
Exercised	-	$	-1,300	$
		-		0.0225
Expired	-4,333	$	-15,063	$
		0.0225		0.0343
Outstanding at end of period	145,411	$	135,359	$
		0.0289		0.0252
Exercisable at end of period	145,411	$	135,359	$
		0.0289		0.0252
A summary of the status of the warrants outstanding and exercisable as of June 30, 2014, is as follows:
Number of Warrants	Weighted Average	Weighted Average
	Remaining Life	Exercise Price per
		share
13,069	0.22	$
		0.0225
123,699	2.28	$
		0.0275
8,643	1.06	$
		0.05
145,411	2.14	$
		0.0289
On May 6, 2014, the Company entered into a $2 million Credit Agreement with Venture Champion Asia Limited, an affiliate of ICG Global Limited (the "Lender"). In connection with the Company's entry into the Credit Agreement, the Company issued the Lender a warrant to purchase approximately 10,909 shares of Common Stock. The warrant has a three year life and is exercisable at $0.0275 per share. The Company ascribed a value of $245, booked as interest expense, to the warrant using the Black Scholes Pricing Model, (See Note 6).
Contingent warrants
Investors that received warrants in connection with the Company's financing transaction in closings that occurred on December 13, 2013, February 7, 2014 and March 6, 2014, may receive additional warrants to purchase up to an aggregate of 120,782 shares of Common Stock, if the Company does not achieve certain revenue targets in the first three quarters of 2014. The Company ascribed a value of $566 to the warrants issued at closing, including the contingent warrants, using a Black Sholes valuation model. The Company also recorded a beneficial conversion feature of $305 related to the shares of Series D Preferred Stock issued in the February 7, 2014 and March 6, 2014 closing, based on the accounting conversion price of the shares of Series D Preferred Stock issued in those closings.
On May 14, 2014 the Company issued 40,262 contingent warrants in connection with the Company's financing transactions referenced above as a result of the Company not achieving its revenue targets in the first quarter ending March 31, 2014.
Since the Company did not achieve the revenue target for the three-month periods ended June 30, 2014, the Company will issue warrants to purchase 40,262 shares of common stock promptly after filing of this Form 10-Q.
At June 30, 2014, 145,411 shares of common stock were reserved for issuance upon exercise of outstanding warrants.

Subsequent_event

Subsequent event	6 Months Ended
	Jun. 30, 2014
Subsequent Event [Abstract]	'
Subsequent event	'
	8. Subsequent Event - Financing
	On August 5, 2014, the Company entered into subscription agreements with certain investors, under which the Company issued an aggregate of 1,120 shares of Series D-1 Preferred Stock at a purchase price of $1.00 per share for an aggregate purchase price of $1,120. The shares of Series D-1 Preferred Stock have a dividend rate of 10% and are convertible into shares of Common Stock at an initial conversion price of $0.0225 per share (subject to adjustment). The Company paid an administrative fee of $50 to SG Phoenix associated with this financing.

Nature_of_business_basis_of_pr1

Nature of business, basis of presentation and summary of significant accounting policies (Policies)	6 Months Ended
	Jun. 30, 2014
Summary of Significant Accounting Policies	'
Basis of presentation	'
	The accompanying unaudited condensed consolidated financial statements of Communication Intelligence Corporation and its subsidiary (the "Company" or "CIC") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("GAAP") for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company's results of operations and cash flows for the periods presented. The Company's interim results are not necessarily indicative of the results to be expected for the entire year.
Going concern and management plans	'
	Going Concern
	The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at June 30, 2014, the Company's accumulated deficit was $121,410. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of June 30, 2014, the Company's cash balance was $415. These factors raise substantial doubt about the Company's ability to continue as a going concern.
	There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Reclassifications	'
	Reclassifications
	Certain prior year amounts have been reclassified between Series C Preferred Stock, Series D-1 Preferred Stock, Series D-2 Preferred Stock and Additional paid in capital on the accompanying condensed consolidated balance sheet to properly reflect accretion of the beneficial conversion feature on certain issuances of the Company's Preferred Stock. These reclassifications do not impact the condensed consolidated statement of operations or the condensed consolidated statement of cash flows.
Recently issued accounting pronouncement	'
	Accounting Changes and Recent Accounting Pronouncements
	Accounting Standards Issued But Not Yet Adopted
	Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies are not expected to have a material impact on the Company's financial position, results of operations and cash flows.
Patents	'
	The Company performs intangible asset impairment analysis at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets.
Derivatives policy	'
	The Company has determined that a contract that would otherwise meet the definition of a derivative but is both (a) indexed to the Company's own stock and (b) classified in stockholders' equity in the statement of financial position would not be considered a derivative financial instrument. The Company applies a two-step model in determining whether a financial instrument or an embedded feature is indexed to an issuer's own stock and thus able to qualify for the scope exception.
Fair Value of Financial Instruments	'
	The Company issued certain warrants in connection with financing transactions from 2010 through 2012 that require liability classification because of certain provisions that may have resulted in an adjustment to the number of shares issued upon settlement and an adjustment to their exercise price. The Company classifies these warrants on its balance sheet as a derivative liability which is fair valued at each reporting period subsequent to the initial issuance. The Company used a simulated probability valuation model to value these warrants. Determining the appropriate fair-value model and calculating the fair value of warrants requires considerable judgment. Any change in the estimates (specifically, probabilities) used may cause the value to be higher or lower than that reported. The assumptions used in the model required significant judgment by management and include the following: volatility, expected term, risk-free interest rate, dividends, and warrant holders' expected rate of return, reset provisions based on expected future financings, projected stock prices, and probability of exercise. The estimated volatility of the Company's common stock at the date of issuance, and at each subsequent reporting period, is based on historical volatility. The risk-free interest rate is based on rates published by the government for bonds with a maturity similar to the expected remaining life of the warrants at the valuation date. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Dividends are estimated at 0% based on the Company's history of no common stock dividends.
Fair value measurement	'
	The fair value framework requires a categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:
	Level 1: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
Net loss per share	'
	The Company calculates basic net loss per share, based on the weighted average number of shares outstanding, and when applicable, diluted income per share, which is based on the weighted average number of shares and potential dilutive shares outstanding.
Share-based payment	'
	Share-based compensation expense is based on the estimated grant date fair value of the portion of share-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black Scholes valuation model.
	Forfeitures of share-based payment awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Concentration_Tables

Concentration (Tables)	6 Months Ended
	Jun. 30, 2014
Risks and Uncertainties [Abstract]	'
Schedule of accounts receivable and revenue concentration	'
	The following table summarizes accounts receivable and revenue concentrations:
		Accounts Receivable		Total Revenue		Total Revenue
		As of June 30,		for the three months		for the six months
				ended June 30,		ended June 30,
		2014	2013	2014	2013	2014	2013
	Customer #1	-	13%	-	-	-	-
	Customer #2	-	-	-	14%	-	14%
	Customer #3	25%	54%	-	-	-	-
	Customer #4	-	-	-	-	11%	-
	Customer #5	44%	-	32%	-	19%	-
	Customer #6	-	14%	-	-	-	-
	Customer #7	-	-	-	13%	-	14%
	Total concentration	69%	81%	32%	27%	30%	28%

Patents_Tables

Patents (Tables)	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Summary of Intangible Assets	'
	The following table summarizes intangible assets:
	Amortizable intangible assets:	30-Jun-14		31-Dec-13
		Carrying	Accumulated	Carrying	Accumulative
		Amount	Amortization	Amount	Amortization
	Patents	$	$	$	$
		6,746	-5,636	6,745	-5,455

Derivative_Liability_Tables

Derivative Liability (Tables)	6 Months Ended
	Jun. 30, 2014
Derivative liability [Abstract]	'
Liabilities measured at fair value	'
	Assets and liabilities measured at fair value as of June 30, 2014 and December 31, 2013:
		Value at	Quoted	Significant	Significant
			prices in	other	unobservable
			active	observable	inputs
			markets	inputs
			(Level 1)	(Level 2)	(Level 3)
		30-Jun-14
	Derivative liability	$	$	$	$
		22	-	-	22
		31-Dec-13
	Derivative liability	$	$	$	$
		25	-	-	25
Changes in the market value of the Level 3 derivative liability	'
	Changes in the fair market value of the Level 3 derivative liability for the six-month period ended June 30, 2014 are as follows:
		Derivative Liability
	Balance at January 1, 2014	$
		25
	Gain on derivative liability	3
	Balance at June 30, 2014	$
		23

Net_loss_per_share_Tables

Net loss per share (Tables)	6 Months Ended
	Jun. 30, 2014
Net loss per share [Abstract]	'
Schedule of Antidilutive Securities Excluded from Calculation of Earnings Per Share	'
	The following table lists shares and warrants that were excluded from the calculation of dilutive earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive:
		For the Six Months Ended
		30-Jun-14	30-Jun-13
	Stock options	71,987	70,472
	Warrants	105,230	135,359
	Preferred shares as if converted
	Series A-1Preferred Stock	7,664	7,079
	Series B Preferred Stock	269,105	243,796
	Series C Preferred Stock	210,412	194,888
	Series D-1 Preferred Stock	195,956	62,818
	Series D-2 Preferred Stock	108,713	87,997
Reconciliation of the numerator (net loss) and the denominator (number of shares) used in the basic and diluted EPS calculations	'
	The following table is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the basic and diluted EPS calculations and sets forth potential shares of common stock that are not included in the diluted net loss per share calculation as the effect is antidilutive:
		Three Months Ended		Six Months Ended
		June 30,	June 30,	June 30,	June 30,
		2014	2013	2014	2013
	Numerator-basic and diluted net loss	$	$	$	$
		-1,851	-1,957	-3,906	-3,686
	Denominator-basic or diluted	232,560	225,824	232,560	225,803
	weighted average number of common
	shares outstanding
	Net loss per share - basic and diluted	$	$	$	$
		-0.01	-0.01	-0.02	-0.02

Equity_Tables

Equity (Tables)	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity [Abstract]	'
Key assumptions for fair value calculation, stock options	'
	The fair value calculations are based on the following assumptions:
		Six Months Ended	Six Months Ended
		30-Jun-14	30-Jun-13
	Risk free interest rate	0.04% - 4.89%	0.39% - 5.11%
	Expected life (years)	3.26 - 7.00	2.82 - 7.00
	Expected volatility	91.99% - 198.38%	91.99% - 198.38%
	Expected dividends	None	None
Allocation of stock-based compensation expense related to stock option grants	'
	The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and six months ended June 30, 2014 and 2013.
		Three Months Ended June 30,		Six Months Ended June 30,
		2014	2013	2014	2013
	Research and development	$	$	$	$
		21	49	48	245
	Sales and marketing	24	17	37	117
	General and administrative	37	100	83	42
	Director options	4	10	9	25
	Stock-based compensation	$	$	$	$
	expense	86	176	177	429
Summary of option activity	'
	A summary of option activity under the Company's plans as of June 30, 2014 and 2013 is as follows:
	Options	2014				2013
		Shares	Weighted	Weighted	Aggregate	Shares	Weighted	Weighted	Aggregate
			Average	Average	Intrinsic		Average	Average	Intrinsic
			Exercise	Remaining	Value		Exercise	Remaining	Value
			Price	Contractual			Price	Contractual
				Term				Term
	Outstanding	69,537	$		$	44,529	$		$
	at January 1,		0.05		-		0.05		2,230
	Granted	2,500	$		$	26,554	$		$
			0.03		7		0.04		1,188
	Exercised	-	$		$	-	$		$
			-		-		-		-
	Forfeited or	-50	$		$	-610	$		$
	expired		0.22		-		0.14		-85
	Outstanding	71,987	$	4.6	$	70,473	$	5.51	$
	at June 30		0.05		7		0.05		3,333
	Vested and	46,864	$	4.24	$	63,615	$	5.51	$
	expected to		0.05		-		0.05		3,009
	vest at June
	30
	Exercisable at	51,984	$	4.24	$	33,083	$	4.94	$
	30-Jun		0.05		-		0.05		1,638
Summary of the significant ranges of outstanding and exercisable options	'
	The following table identifies the range of outstanding and exercisable options as of June 30, 2014:
	Range of Exercise Prices	Options Outstanding			Options Exercisable
		Number	Weighted	Weighted	Number	Weighted
		Outstanding	Average	Average	Outstanding	Average
			Remaining	Exercise		Exercise
			Contractual	Price		Price
			Life (in years)
	$ 0.02 - $0.50	71,987	4.6	$	51,984	$
				0.05		0.05
Summary of the status of the Company's non-vested shares	'
	A summary of the status of the Company's non-vested shares as of June 30, 2014, is as follows:
	Nonvested Shares	Shares	Weighted Average
			Grant-Date
			Fair Value
	Non-vested at January 1, 2014	26,158	$
			0.04
	Granted	2,500	$
			0.03
	Forfeited	-	$
			-
	Vested	-8,655	$
			0.04
	Non-vested at June 30, 2014	20,032	$
			0.04
Information with respect to the classes of Preferred Stock	'
	Information with respect to the class of Preferred Stock at June 30, 2014 is as follows:
	Class of	Annual	Annual	Liquidation	Conversion	YTD	Total	Common
	Preferred	Dividend	Dividend	Preference	Price	Dividend	Preferred	Shares to be
	Stock		Payable, in			Shares in	Shares	issued if
			Cash or In			Kind	Outstanding	Fully
			Kind					Converted
	Series A-1	8%	Quarterly in	$	$	41	1,073	7,664
			Arrears	1	0.14
	Series B	10%	Quarterly in	$	$	558	11,660	269,105
			Arrears	1.5	0.0433
	Series C	10%	Quarterly in	$	$	226	4,734	210,412
			Arrears	1.5	0.0225
	Series D-1	10%	Quarterly in	$	$	201	4,409	195,956
			Arrears	1	0.0225
	Series D-2	10%	Quarterly in	$	$	255	5,436	108,713
			Arrears	1	0.05
Information with respect to dividends issued on the Company's preferred stock	'
	Information with respect to dividends issued on the Company's Preferred stock for the three and six month periods ended June 30, 2014 and June 30, 2013 is as follows:
		Dividends				Beneficial Conversion Feature Related to dividends
		Three Months Ended June 30,		Six Months Ended June 30,		Three Months Ended June 30,		Six Months Ended June 30,
		2014	2013	2014	2013	2014	2013	2014	2013
	Series A-1	$	$	$	$	$	$	$	$
		21	19	41	37	-	-	-	-
	Series B	$	$	$	$	$	$	$	$
		284	257	558	504	-	-	-	-
	Series C	$	$	$	$	$	$	$	$
		115	107	226	210	13	83	50	126
	Series D-1	$	$	$	$	$	$	$	$
		107	31	201	59	12	183	297	195
	Series D-2	$	$	$	$	$	$	$	$
		132	96	255	177	-	-	52	-
	Total	$	$	$	$	$	$	$	$
		659	510	1,281	987	25	266	399	321
Summary of the warrants issued	'
	A summary of the warrant activity is as follows:
		30-Jun-14		30-Jun-13
		Warrants	Weighted	Warrants	Weighted
			Average		Average
			Exercise Price		Exercise Price
	Outstanding at beginning of period	77,155	$	151,722	$
			0.0289		0.0269
	Issued	72,589	$	-	$
			0.0275		-
	Exercised	-	$	-1,300	$
			-		0.0225
	Expired	-4,333	$	-15,063	$
			0.0225		0.0343
	Outstanding at end of period	145,411	$	135,359	$
			0.0289		0.0252
	Exercisable at end of period	145,411	$	135,359	$
			0.0289		0.0252
Status of the warrants outstanding	'
	A summary of the status of the warrants outstanding and exercisable as of June 30, 2014, is as follows:
	Number of Warrants	Weighted Average	Weighted Average
		Remaining Life	Exercise Price per
			share
	13,069	0.22	$
			0.0225
	123,699	2.28	$
			0.0275
	8,643	1.06	$
			0.05
	145,411	2.14	$
			0.0289

Nature_of_business_basis_of_pr2

Nature of business, basis of presentation and summary of significant accounting policies (Details Textual) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'	'	'
Cash and Cash Equivalents, at Carrying Value	$415	$945	$406	$486
Accumulated deficit	($121,410)	($119,184)	'	'

Concentrations_Details

Concentrations (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Accounts Receivable [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	'	69.00%	'
Accounts Receivable [Member] | Customer One [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	'	'	13.00%
Accounts Receivable [Member] | Customer Three [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	'	25.00%	54.00%
Accounts Receivable [Member] | Customer Five [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	'	44.00%	'
Accounts Receivable [Member] | Customer Six [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	'	'	14.00%
Sales Revenue, Services, Net [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	32.00%	27.00%	30.00%	28.00%
Sales Revenue, Services, Net [Member] | Customer Two[Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	14.00%	'	14.00%
Sales Revenue, Services, Net [Member] | Customer Four [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	'	11.00%	'
Sales Revenue, Services, Net [Member] | Customer Five [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	32.00%	'	19.00%	'
Sales Revenue, Services, Net [Member] | Customer Seven [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Concentration risk, percentage	'	13.00%	'	14.00%

Patents_Details

Patents (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Amortizable intangible assets	'	'
Finite-lived intangible assets, gross	$6,746	$6,745
Finite-Lived intangible assets, accumulated amortization	($5,636)	($5,455)

Patents_Details_Textual

Patents (Details Textual) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'	'	'
Patent amortization expense	$89	$91	$180	$183
Patents impairment	$0	$0	$0	$0

Derivative_liability_Details

Derivative liability (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Liabilities measured at fair value	'	'
Derivative liability	$22	$25
Fair Value, Inputs, Level 1 [Member]	'	'
Liabilities measured at fair value	'	'
Derivative liability	'	'
Fair Value, Inputs, Level 2 [Member]	'	'
Liabilities measured at fair value	'	'
Derivative liability	'	'
Fair Value, Inputs, Level 3 [Member]	'	'
Liabilities measured at fair value	'	'
Derivative liability	$22	$25

Derivative_liability_Details_1

Derivative liability (Details 1) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'
Balance at beginning of period	$25
Gain on derivative liability	3
Balance at end of period	$22

Derivative_Liability_Details_T

Derivative Liability (Details Textual) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Derivative Liability, Fair Value, Net [Abstract]	'	'
Fair value of the derivative liability	$22	$25
Annual Dividend	0.00%	'

Net_loss_per_share_Details

Net loss per share (Details)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Series A Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share, shares	7,664	7,079
Series B Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share, shares	269,105	243,796
Series C Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share, shares	210,411	194,888
Series D One Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share, shares	195,955	62,818
Series D Two Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share, shares	108,713	87,997
Stock Options [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share, shares	71,987	70,472
Warrants [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of earnings per share, shares	105,230	135,359

Net_loss_per_share_Details_1

Net loss per share (Details 1) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Earnings Per Share Reconciliation [Abstract]	'	'	'	'
Numerator - basic and diluted net loss	($1,851)	($1,957)	($3,906)	($3,686)
Weighted average common shares outstanding, basic and diluted	232,560	225,824	232,560	225,803
Net loss per share - bacis and diluted	($0.01)	($0.01)	($0.02)	($0.02)

Line_of_credit_Details_Textual

Line of credit (Details Textual) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2014	Jun. 30, 2014	6-May-14
In Thousands, except Per Share data, unless otherwise specified					Venture Champion Asia Limited [Member]	Venture Champion Asia Limited [Member]	Venture Champion Asia Limited [Member]
						Credit Agreement Warrant [Member]	Credit Agreement Warrant [Member]
Line of Credit Facility [Line Items]	'	'	'	'	'	'	'
Line of cerdit, initiation day	'	'	'	'	6-May-14	'	'
Line of credit facility, description	'	'	'	'	'Credit Agreement	'	'
Line of credit facility, unsecured indebtedness, current amount	'	'	'	'	$2,000	'	'
Line of credit facility, unsecured indebtedness, maximum amount	'	'	'	'	2,352	'	'
Line of credit facility period	'	'	'	'	'18 months	'	'
Original issue discount, percentage	'	'	'	'	15.00%	'	'
Number of common shares callable by warrants	'	'	'	'	10,909	'	'
Warrant coverage, maximum percentage	'	'	'	'	50.00%	'	'
Exercise price	$0.03	$0.03	$0.03	$0.03	$0.03	'	'
Expected term	'	'	'	'	'	'3 years	'
Initial fair value of warrants	'	'	'	'	'	'	245
Fair value of warrants booked as interest expense at period end	'	'	'	'	'	$245	'

Equity_Details

Equity (Details) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]	'	'
Risk-free interest rate, minimum	0.04%	0.39%
Risk-free interest rate, maximum	4.89%	5.11%
Expected volatility, minimum	91.99%	91.99%
Expected volatility, maximum	198.38%	198.38%
Expected dividend yield	$0	$0
Minimum [Member]	'	'
Fair value assumptions, stock options	'	'
Expected life	'3 years 3 months 4 days	'2 years 9 months 18 days
Maximum [Member]	'	'
Fair value assumptions, stock options	'	'
Expected life	'7 years	'7 years

Equity_Details_1

Equity (Details 1) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	$86	$176	$177	$429
Research and Development Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	21	49	48	245
Selling and Marketing Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	24	17	37	117
General and Administrative Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	37	100	83	42
Director Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	$4	$10	$9	$25

Equity_Details_2

Equity (Details 2) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Summary of stock options outstanding	'	'	'	'
Stock Options Outstanding, Beginning Balance	'	'	69,537	44,529
Stock Options, Granted	2,500	26,554	2,500	26,554
Stock Options, Exercised	0	0	0	0
Stock Options, Forfeited, or expired	'	'	-50	-610
Stock Options Outstanding, Ending Balance	71,987	70,473	71,987	70,473
Stock Options, Vested and expected to vest at ending balance	46,864	63,615	46,864	63,615
Options exercisable	51,984	33,083	51,984	33,083
Weighted Average Exercise Price, Beginning Period	'	'	$0.05	$0.05
Weighted Average Exercise Price, Granted	'	'	$0.03	$0.04
Weighted Average Exercise Price, Exercised	'	'	'	'
Weighted Average Exercise Price, Forfeited, or expired	'	'	$0.22	$0.14
Weighted Average Exercise Price, Ending Period	$0.05	$0.05	$0.05	$0.05
Weighted Average Exercise Price, Vested and expected to vest at ending balance	$0.05	$0.05	$0.05	$0.05
Weighted Average Exercise Price, Exercisable at ending balance	$0.05	$0.05	$0.05	$0.05
Weighted Average Remaining Contractual Term, ending balance	'	'	'4 years 7 months 1 day	'5 years 6 months 4 days
Weighted Average Remaining Contractual Term, vested and expected to vest at ending balance	'	'	'4 years 2 months 27 days	'5 years 6 months 4 days
Weighted Average Remaining Contractual Term, excercisable at ending balance	'	'	'4 years 2 months 27 days	'4 years 9 months 1 day
Aggregate Intrinsic Value, Beginning Balance	'	'	'	$2,230
Aggregate Intrinsic Value, Granted	'	'	7	1,188
Aggregate Intrinsic Value, Exercised	'	'	'	'
Aggregate Intrinsic Value, Forfeited or expired	'	'	'	85
Aggregate Intrinsic Value, Ending Balance	7	3,333	7	3,333
Aggregate Intrinsic Value, Vested and expected to vest at ending balance	'	3,009	'	3,009
Aggregate Intrinsic Value, Exercisable at ending balance	'	$1,638	'	$1,638

Equity_Details_3

Equity (Details 3) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
In Thousands, except Per Share data, unless otherwise specified			Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'
Exercise Price Range, Lower Range Limit	'	'	$0.02
Exercise Price Range, Upper Range Limit	'	'	$0.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract]	'	'	'
Number of Outstanding Options	'	'	71,987
Outstanding Options, Weighted Average Remaining Contractual Term	'	'	'4 years 7 months 1 day
Outstanding Options, Weighted Average Exercise Price	$0.03	$0.04	$0.05
Exercise Price Range, Number of Exercisable Options	'	'	51,984
Exercisable Options, Weighted Average Exercise Price	'	'	$0.05

Equity_Details_4

Equity (Details 4) (USD $)	6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014
Equity Instruments, Options, Nonvested Shares Roll-Forward	'
Non-vested shares, Beginning Balance	26,158
Non-vested shares, Granted	2,500
Non-vested shares, Forfeited, or expired	'
Non-vested shares, vested	-8,655
Stock Options Outstanding, Ending Balance	20,003
Weighted Average Grant Date Fair Value, Options Nonvested at beginning of period	$0.04
Weighted Average Grant Date Fair Value, Options nonvested, grants in period	$0.03
Weighted Average Grant Date Fair Value, Options nonvested, forfeited in period	'
Weighted Average Grant Date Fair Value, Options nonvested, vested in period	$0.04
Weighted Average Grant Date Fair Value, Options nonvested at end of period	$0.04

Equity_Details_5

Equity (Details 5) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Annual Dividend	'	'	0.00%	'	'
Dividends, Preferred Stock	$659,000	$510,000	$1,281,000	$987,000	'
Common Shares to be Issued if Fully Converted	772,624,000	'	772,624,000	'	'
Series A Preferred Stock [Member]	'	'	'	'	'
Annual Dividend	'	'	8.00%	'	'
Annual Dividend Payable, in Cash or In Kind	'	'	'Quarterly in Arrears	'	'
Liquidation preference	1	'	1	'	'
Conversion price	$0.14	'	$0.14	'	'
Dividends, Preferred Stock	21,000	19,000	41,000	37,000	'
Total Preferred Shares Outstanding	1,073,000	'	1,073,000	'	1,031,000
Common Shares to be Issued if Fully Converted	7,664,000	'	7,664,000	'	'
Series B Preferred Stock [Member]	'	'	'	'	'
Annual Dividend	'	'	10.00%	'	'
Annual Dividend Payable, in Cash or In Kind	'	'	'Quarterly in Arrears	'	'
Liquidation preference	1.5	'	1.5	'	'
Conversion price	$0.04	'	$0.04	'	'
Dividends, Preferred Stock	284,000	257,000	558,000	504,000	'
Total Preferred Shares Outstanding	11,660,000	'	11,660,000	'	11,102,000
Common Shares to be Issued if Fully Converted	269,105,000	'	269,105,000	'	'
Series C Preferred Stock [Member]	'	'	'	'	'
Annual Dividend	'	'	10.00%	'	'
Annual Dividend Payable, in Cash or In Kind	'	'	'Quarterly in Arrears	'	'
Liquidation preference	1.5	'	1.5	'	'
Conversion price	$0.02	'	$0.02	'	'
Dividends, Preferred Stock	115,000	107,000	226,000	210,000	'
Total Preferred Shares Outstanding	4,734,000	'	4,734,000	'	4,508,000
Common Shares to be Issued if Fully Converted	210,412,000	'	210,412,000	'	'
Series D One Preferred Stock [Member]	'	'	'	'	'
Annual Dividend	'	'	10.00%	'	'
Annual Dividend Payable, in Cash or In Kind	'	'	'Quarterly in Arrears	'	'
Liquidation preference	1	'	1	'	'
Conversion price	$0.02	'	$0.02	'	'
Dividends, Preferred Stock	107,000	31,000	201,000	59,000	'
Total Preferred Shares Outstanding	4,409,000	'	4,409,000	'	3,415,000
Common Shares to be Issued if Fully Converted	195,956,000	'	195,956,000	'	'
Series D Two Preferred Stock [Member]	'	'	'	'	'
Annual Dividend	'	'	10.00%	'	'
Annual Dividend Payable, in Cash or In Kind	'	'	'Quarterly in Arrears	'	'
Liquidation preference	1	'	1	'	'
Conversion price	$0.05	'	$0.05	'	'
Dividends, Preferred Stock	$132,000	$96,000	$255,000	$177,000	'
Total Preferred Shares Outstanding	5,436,000	'	5,436,000	'	4,783,000
Common Shares to be Issued if Fully Converted	108,713,000	'	108,713,000	'	'

Equity_Details_6

Equity (Details 6) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Dividends Net of Beneficial Conversion Feature	$659	$510	$1,281	$987
Accretion of beneficial conversion feature related to dividends	25	266	399	321
Series A Preferred Stock [Member]	'	'	'	'
Dividends Net of Beneficial Conversion Feature	21	19	41	37
Accretion of beneficial conversion feature related to dividends	'	'	'	'
Series B Preferred Stock [Member]	'	'	'	'
Dividends Net of Beneficial Conversion Feature	284	257	558	504
Accretion of beneficial conversion feature related to dividends	'	'	'	'
Series C Preferred Stock [Member]	'	'	'	'
Dividends Net of Beneficial Conversion Feature	115	107	226	210
Accretion of beneficial conversion feature related to dividends	13	83	50	126
Series D One Preferred Stock [Member]	'	'	'	'
Dividends Net of Beneficial Conversion Feature	107	31	201	59
Accretion of beneficial conversion feature related to dividends	12	183	297	195
Series D Two Preferred Stock [Member]	'	'	'	'
Dividends Net of Beneficial Conversion Feature	132	96	255	177
Accretion of beneficial conversion feature related to dividends	'	'	$52	'

Equity_Details_7

Equity (Details 7) (USD $)	6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Class Of Warrant Or Right Number Of Warrants Or Rights Roll Forward	'	'
Number of Warrants Outstanding at beginning of period	77,155	151,722
Number of warrants issued	72,589	'
Number Of Warrants Or Rights Exercised	'	-1,300
Number Of Warrants Or Rights Expired	-4,333	-15,063
Number of Warrants Outstanding at end of period	145,411	135,359
Number of Warrants Or Rights Exercisable at end of period	145,411	135,359
Excercise Price of Warrants Outstanding at beginning of period	$0.03	$0.03
Exercise Price Of Warrants Issued	$0.03	'
Exercise Price Of Warrants Exercised	'	$0.02
Exercise Price Of Warrants Expired	$0.02	$0.03
Excercise Price of Warrants Outstanding at end of period	$0.03	$0.03
Exercise Price Of WarrantsExercisable at end of period	$0.03	$0.03

Equity_Details_8

Equity (Details 8) (USD $)	6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
Class of Warrant or Right [Line Items]	'	'	'	'
Number of Warrants Outstanding and Excercisable	145,411	77,155	135,359	151,722
Weighted Average Remaining Life Of Warrants Or Rights	'2 years 4 months 17 days	'	'	'
Warrants Weighted Average Exercise Price	$0.03	$0.03	$0.03	$0.03
Warrants Group One [Member]	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'
Number of Warrants Outstanding and Excercisable	13,069	'	'	'
Weighted Average Remaining Life Of Warrants Or Rights	'2 months 19 days	'	'	'
Warrants Weighted Average Exercise Price	$0.02	'	'	'
Warrants Group Two [Member]	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'
Number of Warrants Outstanding and Excercisable	123,699	'	'	'
Weighted Average Remaining Life Of Warrants Or Rights	'2 years 3 months 11 days	'	'	'
Warrants Weighted Average Exercise Price	$0.03	'	'	'
Warrants Group Three [Member]	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'
Number of Warrants Outstanding and Excercisable	8,643	'	'	'
Weighted Average Remaining Life Of Warrants Or Rights	'1 year 3 months 22 days	'	'	'
Warrants Weighted Average Exercise Price	$0.05	'	'	'

Equity_Details_Textual

Equity (Details Textual) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Share-based Arrangements with Employees and Nonemployees [Abstract]	'	'	'	'
Estimated average forfeiture rate	'	'	9.85%	9.73%
Stock Options, Granted	2,500	26,554	2,500	26,554
Outstanding Options, Weighted Average Exercise Price	$0.03	$0.04	$0.03	$0.04
Stock Options, Exercised	0	0	0	0
Total unrecognized compensation expense related to non-vested share-based compensation arrangements granted under the plans	$317	'	$317	'
Unrecognized compensation expense amortization period	'	'	'2 years 0 months 29 days	'

Equity_Details_Textual_1

Equity (Details Textual 1) (USD $)

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2012

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Feb. 28, 2014

Dec. 31, 2013

31-May-13

Mar. 31, 2014

Feb. 28, 2014

Dec. 31, 2013

31-May-13

Feb. 07, 2014

Mar. 31, 2014

Feb. 28, 2014

Dec. 31, 2013

31-May-13

Feb. 07, 2014

Dec. 31, 2013

Jun. 30, 2014

31-May-14

Jun. 30, 2014

Nov. 30, 2012

Jun. 30, 2014

Jun. 30, 2014

6-May-14

In Thousands, except Share data, unless otherwise specified

Warrants Issued to SG Phoenix [Member]

Warrants Issued to SG Phoenix [Member]

Warrants Issued to Unrelated Parties [Member]

Warrants Issued to Unrelated Parties [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D One Preferred Stock [Member]

Series D One Preferred Stock [Member]

Series D One Preferred Stock [Member]

Series D One Preferred Stock [Member]

Series D One Preferred Stock [Member]

Series D Two Preferred Stock [Member]

Series D Two Preferred Stock [Member]

Series D Two Preferred Stock [Member]

Series D Two Preferred Stock [Member]

Series D Two Preferred Stock [Member]

Series D Two Preferred Stock For Cash [Member]

February And March Two Thousand Fourteen Note And Warrant Purchase Agreement [Member]

February And March Two Thousand Fourteen Note And Warrant Purchase Agreement [Member]

February And March Two Thousand Fourteen Note And Warrant Purchase Agreement [Member]

Series D Financing [Member]

Venture Champion Asia Limited [Member]

Venture Champion Asia Limited [Member]

Venture Champion Asia Limited [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Contingent Warrants [Member]

Contingent Warrants [Member]

Contingent Warrants [Member]

Credit Agreement Warrant [Member]

Credit Agreement Warrant [Member]

Subsequent Event [Member]

Subsidiary, Sale of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Units, Issued

'

'

'

'

'

'

'

'

'

'

'

230,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Units, Components

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1

2

'

'

'

4

1

'

'

'

'

'

'

'

'

Preferred Units, Description

'

'

'

'

'

'

'

'

'

'

'

'Units of Series D Preferred Shares consisting of one (1) share of Series D-1 Preferred Stock with an exercise price of $0.0025 per share and four (4) shares of Series D-2 Preferred Stock at an exercise price of $0.05 per share.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from sale of stock, net

'

'

'

'

'

'

'

'

$406

$733

$870

$1,150

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Administrative fee paid to SG Phoenix

'

'

'

'

'

'

'

'

4

47

40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares sold in private placement

'

'

'

'

'

'

'

'

'

'

'

'

273,000

520,000

607,000

'

'

137,000

260,000

303,000

'

'

'

'

'

'

'

'

'

'

Conversion of short-term debt and accrued interest, net of offering costs

'

'

'

'

'

'

'

'

'

'

1,179

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,099

'

'

'

Shares issued in debt conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

786,000

'

'

'

'

393,000

'

'

'

'

'

'

'

'

'

'

Warrant coverage, maximum percentage

'

'

'

'

'

'

'

'

100.00%

100.00%

100.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

Fair Value Assumptions, Expected Term

'

'

'

'

'3 years

'

'3 years

'

'

'

'3 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

'

Number of shares of Series D-2 Preferred Stock exchanged into Series D-1 Preferred Stock

'

'

'

'

'

'

'

'

'

'

537,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants, expiration date

'

'

'

'

'

'

'

'

31-Dec-16

31-Dec-16

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of common shares callable by warrants

'

'

'

'

'

3,000,000

'

1,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

120,782,000

40,262,000

40,262,000

'

10,909,000

'

'

Number of common shares, reserved for issuance upon exercise of outstanding warrants

145,411,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase price per share for the shares sold in private placement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

'

'

Fair value of contingent warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

566

'

'

'

'

'

'

Debt Instrument, Convertible, Beneficial Conversion Feature

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

305

'

'

'

'

'

'

Line of cerdit, initiation day

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6-May-14

'

'

Line of credit facility, description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Credit Agreement

'

'

Line of credit facility, unsecured indebtedness, current amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000

'

'

Exercise price

$0.03

$0.03

$0.03

$0.03

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.03

'

'

Initial fair value of warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$245

Subsequent_Event_Details_Textu

Subsequent Event (Details Textual) (USD $)	6 Months Ended	1 Months Ended			6 Months Ended	1 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Mar. 31, 2014	Feb. 28, 2014	Dec. 31, 2013	Jun. 30, 2014	Aug. 31, 2014	Aug. 05, 2014
		Series D One Preferred Stock [Member]	Series D One Preferred Stock [Member]	Series D One Preferred Stock [Member]	Series D One Preferred Stock [Member]	Subsequent Event [Member]	Subsequent Event [Member]
						Subscription Agreements [Member]	Subscription Agreements [Member]
						Series D One Preferred Stock [Member]	Series D One Preferred Stock [Member]
Subsequent Event [Line Items]	'	'	'	'	'	'	'
Subsequent Event, Date	'	'	'	'	'	5-Aug-14	'
Subsequent Event, Description	'	'	'	'	'	'Subscription Agreements with certain investors	'
Number of shares sold in private placement	'	273	520	607	'	1,120	'
Purchase price per share for the shares sold in private placement	'	'	'	'	'	'	$1
Aggregate purchase price	'	'	'	'	'	$1,120	'
Annual Dividend	0.00%	'	'	'	10.00%	10.00%	'
Conversion price per share	'	'	'	'	'	'	$0.02
Administrative fee paid to SG Phoenix	'	'	'	'	'	$50	'